Expression of PAI-1 in human visceral and subcutaneous fat and its correlation with blood plasma PAI-1 levels

被引：0
|
作者：
Polac, I
Cierniewska-Cieslak, A
Pertynski, T
Szylo, K
Cierniewski, CS
机构：
[1] Polish Mothers Mem Res Inst, Lodz, Poland
[2] Polish Acad Sci, Ctr Microbiol & Virol, Lodz, Poland
来源：
THROMBOSIS AND HAEMOSTASIS | 1999年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2479
引用
收藏
页码：783 / 784
页数：2
相关论文
共 50 条
  • [31] DAYTIME FLUCTUATIONS OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) IN POPULATIONS WITH HIGH PAI-1 LEVELS
    JUHANVAGUE, I
    ALESSI, MC
    RACCAH, D
    AILLAUD, MF
    BILLEREY, M
    ANSALDI, J
    PHILIPJOET, C
    VAGUE, P
    THROMBOSIS AND HAEMOSTASIS, 1992, 67 (01) : 76 - 82
  • [32] STABILIZATION OF PAI-1 BY AN ANTIBODY SPECIFIC FOR ACTIVE PAI-1, COMPARED TO THE EFFECT OF VITRONECTIN
    EHNEBOM, J
    BJORQUIST, P
    PUSA, S
    DEINUM, J
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1009 - 1009
  • [33] The 4G5G polymorphism in the gene for PAI-1 and the circadian oscillation of plasma PAI-1
    van der Bom, JG
    Bots, ML
    Haverkate, F
    Kluft, C
    Grobbee, DE
    BLOOD, 2003, 101 (05) : 1841 - 1844
  • [34] tPA,PAI-1 and tPA/PAI-1 complex as rifactors for the development of a first stroke
    Boman, K
    Johansson, L
    Jansson, JH
    Stegmayr, B
    Hallmans, G
    CIRCULATION, 1999, 100 (18) : 181 - 181
  • [35] The Biochemistry, Physiology and Pathological roles of PAI-1 and the requirements for PAI-1 inhibition in vivo
    Van de Craen, Britt
    Declerck, Paul J.
    Gils, Ann
    THROMBOSIS RESEARCH, 2012, 130 (04) : 576 - 585
  • [36] Targeting PAI-1 in Cardiovascular Disease: Structural Insights Into PAI-1 Functionality and Inhibition
    Sillen, Machteld
    Declerck, Paul J.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2020, 7
  • [37] Posttranscriptional regulation of PAI-1 gene expression
    Heaton, JH
    Dlakic, WM
    Gelehrter, TD
    THROMBOSIS AND HAEMOSTASIS, 2003, 89 (06) : 959 - 966
  • [38] Visceral obesity, leptin and insulin resistance, but not 4G/5G PAI-1 polymorphism, are important metabolic modulators of plasma PAI-1 levels.
    Calatrava, MJM
    Sánchez, JLG
    Zabena, C
    Larrad, MTM
    Pérez, CF
    Rios, MS
    INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 : S108 - S108
  • [39] Tintelize tPA•PAI-1, a new method for the measurement of TPA•-PAI-1 complexes
    Bergsdorf, N
    Wiman, B
    Norrman, B
    THROMBOSIS AND HAEMOSTASIS, 1999, : 123 - 123
  • [40] VITRONECTIN AND PAI-1 ACTIVITY IN UMBILICAL BLOOD
    MEGURO, T
    TAKI, M
    TAKAYAMA, S
    ITO, H
    SHIGA, K
    YAMADA, K
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1326 - 1326
12345